Regencell Bioscience Holdings Ltd (NASDAQ:RGC)
| 30.00 Delayed Data As of Dec 02 |  -0.80 / -2.66%Today’s Change | 20.54 Today|||52-Week Range 48.29 | -5.81% Year-to-Date |
Latest RGC News | Press Releases
No recent news for Regencell Bioscience Holdings Ltd.
Today’s Trading
| Previous close | 30.13 |
| Today’s open | 29.33 |
| Day’s range | 29.33 - 29.33 |
| Volume | 208 |
| Average volume (3 months) | 1,845 |
| Market cap | $394.3M |
Data as of 3:56pm ET, 12/02/2022
Growth & Valuation
| Earnings growth (last year) | -447.98% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 23.10 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$7.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
Chart unavailable
